Practice Agreement · PharmD
Ohio Consult Agreement for Pharmacists
Required. The Consult Agreement is the written instrument Ohio law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.
Four distinct, physician/protocol-gated pathways — none is a broad standing-order or population-level authority the way some other states allow. Whether Ohio pharmacists may furnish hormonal contraceptives without a prescription is genuinely disputed between two secondary trackers (Guttmacher says no as of 4/17/2026; NASPA, dated later, lists Ohio as yes but with no citation); coded as NOT currently authorized since no enacting statute could be located for either position. PrEP/PEP furnishing is confirmed NOT authorized.
Independent practice requires: Consult Agreement (Ohio Rev. Code §4729.39, OAC 4729:1-6-02) — per-patient, per-diagnosis drug therapy management with a physician/PA/CNS/CNM/CNP who already has an ongoing relationship with that patient for that diagnosis; valid up to 2 years; OR immunization authority (§4729.41) for ages ≥13 under a physician-established protocol; OR naloxone dispensing (§4729.44) under a physician- or local-health-board-established protocol (no statewide standing order in Ohio); OR (eff. 1/1/2026) epinephrine dispensing without a prescription (§4729.47) under a protocol established by a physician OR — per the 2025 'Global Signature' law, SB 196 — a CNM/CNS/CNP.
What a Ohio Consult Agreement must contain
Governed by the State Board of Pharmacy of Ohio. Each numbered item is a statutory requirement the agreement must satisfy.
The Pharmacist shall manage the patient's drug therapy only pursuant to a written consult agreement with the Physician (or a verbal consult agreement immediately reduced to writing). Before entering into the consult agreement, the Physician must have an ongoing practitioner-patient relationship with each patient covered, the diagnosis or disease state covered must be within the Physician's scope of practice, and the Pharmacist must have training and experience relevant to that diagnosis or disease state.
Source: Ohio Rev. Code § 4729.39
The consult agreement shall set out the procedures, decision criteria, and plan the Pharmacist is to follow, the reasonable parameters of the activities the Pharmacist may undertake, and a description of the tests the Pharmacist may order in connection with managing that drug therapy.
Source: Ohio Admin. Code 4729:1-6-02
- The Consult Agreement on file also carries 1 scope, 1 registration, 1 authority clauses, generated in the document itself.
Statutes and rules cited
- Ohio Rev. Code § 4729.39statute
Authorizes a pharmacist to manage drug therapy under a written consult agreement with a physician (or a PA/APRN authorized by a physician).
- Ohio Admin. Code 4729:1-6-02regulation
Required contents, duration, and recordkeeping for a pharmacist consult agreement.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Separate prescribing terms required · controlled substances permitted
Requires state board controlled-substance registration and DEA registration (with limited hospital-institutional exceptions), plus an OARRS report covering ≥1 year reviewed before adding any controlled substance to a patient's regimen. Schedule II specifically: a pharmacist may not modify the prescribed drug at all except for legally permitted substitutions or correcting the prescriber's signature/patient's name — any other change requires prescriber consultation.
Written agreement
Required
True for all three pathways — a physician-originated document (consult agreement, or physician/health-department protocol) is required in every verified scope-expansion; there is no default independent scope beyond core dispensing/counseling.
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — A pharmacy's 'terminal distributor of dangerous drugs' (TDDD) license can reportedly be held by an individual, partnership, LLC, or corporation regardless of pharmacist licensure — but a licensed pharmacist must separately be named as the 'responsible person' (Ohio Rev. Code §4729.54/§4729.55), bearing statutory responsibility for drug safeguards/records, and may serve as responsible person for only one pharmacy absent special board permission. This functionally constrains operational control even where equity ownership isn't restricted.
Could not confirm a clean statutory statement either allowing or barring non-pharmacist EQUITY ownership specifically — the responsible-person requirement is confirmed, but whether it implies an ownership restriction too is unresolved.
Legal sources for these rules (8)
- Ohio Rev. Code §4729.39 — Consult agreements
- OAC 4729:1-6-02 — Consult agreement requirements (via Cornell LII mirror, read directly)secondary
- Ohio Rev. Code §4729.41 — Adult immunizations
- Ohio Rev. Code §4729.44, OAC 4729:1-3-04 — Naloxone dispensing
- Ohio Rev. Code §4729.47 — Epinephrine dispensing without a prescription, eff. 1/1/2026, confirmed verbatim in a follow-up passsecondary
- SB 196 (2025, 'Global Signature' law) — extends epinephrine-protocol authority to CNM/CNS/CNPsecondary
- Ohio Rev. Code §4729.54, §4729.55 — TDDD licensing, 'responsible person' requirement
- Guttmacher Institute — pharmacist-prescribed-contraceptives tracker (as of 4/17/2026, Ohio NOT listed) — conflicts with a NASPA resource (dated later, through 7/9/2026) listing Ohio with no citation; a candidate enacting bill (H.B. 248) could not be confirmed as ever passed across 5 General Assemblies of reintroduction — unresolved, coded conservatively
About Ohio's rules
Ohio recently relaxed CRNA supervision from 'immediate presence' to facility-wide 'collaboration' (H.B. 52, eff. 6/8/2026, now current law), and will loosen RN laser-delegation rules similarly (H.B. 377, eff. 8/25/2026 — NOT yet law as of this file's date). No independent-practice pathway exists for NP/PMHNP/PA despite active pending reform bills (a 2,000-hour NP threshold, PA proximity removal) — none enacted. Ohio has no corporate-practice-of-medicine doctrine (State Medical Board, 2012). Non-nurse midwifery has no current licensure pathway.
Other clinicians in Ohio: see the state overview.